院外急诊儿童用药偏离国家剂量推荐
该研究基于2020至2021年约2000家急救医疗服务机构的院外儿科(<18岁)患者记录,评估常用药物剂量偏离国家指南(定义为偏离体重适宜剂量≥20%)的情况。在990497次儿科接诊中,63963次(6.4%)接受了至少1种非雾化药物,其中53.9%为研究药物。有体重记录(80.3%)且接受研究药物的接诊中,总体与国家指南一致性为42.6/100次给药。甲泼尼龙(75.1%)、肌注肾上腺素(67.9%)和酮咯酸(56.4%)一致性最高,地西泮(19.5%)和劳拉西泮(21.2%)最低。大多数偏离为剂量不足,劳拉西泮(74.7%)和吗啡(73.8%)最突出。
要点
- 院外儿科常用药物体重剂量与国家指南总体一致性仅42.6/100次给药,地西泮(19.5%)和劳拉西泮(21.2%)最低。
- 大多数剂量偏离为剂量不足,劳拉西泮(74.7%)和吗啡(73.8%)剂量不足比例最高。
- 甲泼尼龙(75.1%)、肌注肾上腺素(67.9%)和酮咯酸(56.4%)与国家指南一致性最高。
- 研究纳入2020至2021年约2000家急救医疗服务机构的990497次儿科接诊,其中63963次(6.4%)接受至少1种非雾化药物。
- 作者认为解决剂量偏离应成为未来教育、质量改进和研究活动的目标。
适用人群与场景
- 院外急救环境中<18岁儿童,来自2020至2021年约2000家急救医疗服务机构的接诊记录。
- 接受至少1种非雾化药物的儿科接诊,其中53.9%的给药为研究药物(劳拉西泮、地西泮、咪达唑仑、芬太尼、氢吗啡酮、吗啡、酮咯酸、肌注肾上腺素、苯海拉明、静脉肾上腺素、甲泼尼龙)。
- 分析限于有体重记录的接诊(80.3%)。
诊断标准与关键阈值
- 剂量偏离定义为偏离国家指南体重适宜剂量≥20%。
研究设计与关键结果
- 研究类型为基于院外急救登记数据库的分析,纳入2020至2021年约2000家急救医疗服务机构的990497次儿科(<18岁)接诊。
- 63963次(6.4%)接诊接受了至少1种非雾化药物,其中53.9%的给药为研究药物。
- 有体重记录(80.3%)且接受研究药物的接诊中,总体与国家指南一致性为42.6/100次给药。
- 一致性最高的药物:甲泼尼龙75.1%、肌注肾上腺素67.9%、酮咯酸56.4%。
- 一致性最低的药物:地西泮19.5%、劳拉西泮21.2%。
- 大多数偏离为剂量不足,劳拉西泮74.7%、吗啡73.8%剂量不足比例最高。
- 按年龄计算体重估计剂量时结果相似。
证据类型、等级与局限
- 证据类型:基于院外急救登记数据库的观察性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,院外儿科常用药物体重剂量与国家指南存在差异,可能归因于方案差异或剂量错误,解决这些问题应成为未来教育、质量改进和研究活动的目标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Previous evaluations of medication dosing variance for children in the prehospital setting have been limited regionally or to specific conditions. We sought to describe pediatric dosing deviations from nationally recommended guidelines for commonly administered medications from a registry of prehospital encounters.
METHODS: We evaluated prehospital patient care records for children (<18 years) from approximately 2000 emergency medical services agencies from 2020 to 2021. We investigated dosing deviations (defined as being ≥20% of the weight-appropriate dose from national guidelines) for the following: lorazepam, diazepam, and midazolam for seizures; fentanyl, hydromorphone, morphine, and ketorolac; intramuscular epinephrine and diphenhydramine for children with allergy or anaphylaxis; intravenous epinephrine; and methylprednisolone.
RESULTS: Of 990 497 pediatric encounters, 63 963 (6.4%) received at least 1 nonnebulized medication. Among nonnebulized doses, 53.9% were for the studied drugs. Among encounters who received a study drug and which had a documented weight (80.3%), the overall consistency with national guidelines was 42.6 per 100 administrations. Appropriate dosing was most common with methylprednisolone (75.1%), intramuscular epinephrine (67.9%), and ketorolac (56.4%). Medications with the lowest consistency with national guidelines were diazepam (19.5%) and lorazepam (21.2%). Most deviations represented an underdose, which was greatest with lorazepam (74.7%) and morphine (73.8%). Results were similar when estimating dosages from weights calculated by age.
CONCLUSIONS: We identified variance in weight-based dosing from national guidelines for common pediatric medications in the prehospital setting, which may be attributable to protocol differences or dosing errors. Addressing these should be a target for future educational, quality improvement, and research activities.
参考来源
- Ramgopal S, Martin-Gill C. Deviation From National Dosing Recommendations for Children Having Out-of-Hospital Emergencies. Pediatrics. 2023. PMID: 37424429. doi:10.1542/peds.2023-061223
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。